Physician

Michael Thomas Avery, DO

According to 2025 Medicare claims, Michael Avery, DO (NPI: 1255568069) practices rheumatology in the Green Bay, WI market, with the plurality of this provider's patient population coming from Brown, WI. This provider's primary affiliated billing organization is ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS OF GREEN BAY, SC (NPI: 1760670145; TIN: 261132759) and primary practice location at 54311-6213. Avery is affiliated with the OSF Healthcare System (ACO ID: A3289), AdvantagePoint Health Alliance - Great Lakes, LLC (ACO ID: A4652), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Avery's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 479 traditional Medicare patients, billed 83,860 HCPCS/CPT codes, and received $1,303,985 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 5,441 prescription claims across 777 beneficiaries totaling $3,578,974 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 27 records totaling $448. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $49,960 to $1,303,985. Similarly, Part D prescription costs have risen steadily, from $214,967 to $3,578,974. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	313	1,710	$49,960
2016	394	855	$40,142
2017	467	17,771	$304,068
2018	311	38,600	$650,075
2019	374	40,643	$861,038
2020	342	38,228	$702,431
2021	453	68,714	$1,113,251
2022	466	65,759	$1,088,050
2023	488	74,756	$1,422,618
2024	479	83,860	$1,303,985

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	213	1,602	$214,967
2016	285	2,248	$292,121
2017	421	1,996	$443,963
2018	394	1,909	$353,897
2019	458	2,744	$635,076
2020	436	3,082	$915,861
2021	560	3,351	$1,316,550
2022	625	4,034	$2,103,008
2023	750	4,842	$3,321,868
2024	777	5,441	$3,578,974

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	113	289	$94
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	252	399	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	94	117	$50
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	192	269	$11
J7050	Infusion, normal saline solution, 250 cc	169	436	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	137	4,032	$1,129,063
Enbrel Sureclick	Etanercept	96	2,968	$775,896
Xeljanz Xr	Tofacitinib Citrate	56	1,680	$323,832
Enbrel	Etanercept	40	1,120	$301,113
Actemra Actpen	Tocilizumab	35	1,204	$178,183

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$448	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael Thomas Avery, DO?

Tedicare shows public-source Medicare data for Michael Thomas Avery, DO (NPI 1255568069), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Thomas Avery, DO have ACO affiliation data?

Michael Thomas Avery, DO is shown with ACO affiliation data for OSF Healthcare System (MSSP, ACO ID A3289), AdvantagePoint Health Alliance - Great Lakes, LLC (MSSP, ACO ID A4652), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Michael Thomas Avery, DO?

Michael Thomas Avery, DO is linked to ORTHOPEDIC & SPORTS MEDICINE SPECIALISTS OF GREEN BAY, SC (billing NPI 1760670145) in the available physician profile data.

Does Michael Thomas Avery, DO have Open Payments data?

Michael Thomas Avery, DO has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.